title: Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma.
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.|Department of Medicine, Weill-Cornell Medical College, New York, NY, USA.
authors.forename: John
authors.initials: J
authors.lastname: Gerecitano
authors.affiliation: Department of Medicine, UCLA Medical Center, Los Angeles, CA, USA.
authors.forename: Sivaraman
authors.initials: S
authors.lastname: Gounder
authors.affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Julie
authors.initials: J
authors.lastname: Teruya-Feldstein
authors.affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Maria
authors.initials: M
authors.lastname: Arcila
authors.affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Shahiba
authors.initials: S
authors.lastname: Ogilvie
authors.affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Camille
authors.initials: C
authors.lastname: Gonzalez
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.|Department of Medicine, Weill-Cornell Medical College, New York, NY, USA.
authors.forename: Dorothy
authors.initials: D
authors.lastname: Lin
authors.affiliation: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Junting
authors.initials: J
authors.lastname: Zheng
authors.affiliation: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Zhigang
authors.initials: Z
authors.lastname: Zhang
authors.affiliation: Millennium Pharmaceuticals, The Takeda Oncology Company, Cambridge, MA, USA.
authors.forename: Alice
authors.initials: A
authors.lastname: McDonald
authors.affiliation: Millennium Pharmaceuticals, The Takeda Oncology Company, Cambridge, MA, USA.
authors.forename: George
authors.initials: G
authors.lastname: Mulligan
authors.affiliation: NYU Langone Medical Center, NYU Cancer Institute, New York, NY, USA.
authors.forename: Owen A
authors.initials: OA
authors.lastname: O'Connor
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000378:metabolism; D040081:Protein Array Analysis / Q000379:methods; D011719:Pyrazines / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D001897:Boronic Acids; D009363:Neoplasm Proteins; D011719:Pyrazines; D000069286:Bortezomib